Myeloproliferative Neoplasms clinical trials at UC Irvine
1 in progress, 0 open to eligible people
A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the efficacy and safety of itacitinib combined with low-dose ruxolitinib or itacitinib alone in subjects with myelofibrosis.
Orange, California and other locations